‘Kiểm Soát Ung Thư’: Hiểu Lựa Chọn Của Phụ Nữ Về Phẫu Thuật Cắt Tuyến Vú

National Institutes of Health. Treatment of early-stage breast cancer. June 18–21 1990. JAMA. 1991;265:391–5. Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 NIH Consensus Development Conference. Cancer. 1999;86:628–37. Gaudette LA, Goa RN, Spence A, Shi F, Joahnesen H, et al. Declining use of mastectomy for invasive breast cancer in Canada, 1981–2000. Can J Public Health. 2004;95:336–40. de Koning HJ, van Dongen JA, van der Maas PJ. Changes in use of breast-conserving therapy in years 1978–2000. Br J Cancer. 1994;70:1165–70. Harries SA, Lawrence RN, Scrivener R, Fieldman NR, Kissin MW. A survey of the management of breast cancer in England and Wales. Ann R Coll Surg Engl. 1996;78:197–202. Neuburger J, Macneill F, Jeevan R, et al. Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ Open. 2013;3:e003179. Jones NB, Wilson J, Kotur L, et al. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–96. Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–09. Dragun AE, Huang B, Tucker TC, et al. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. 2012;18:318–25. Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates. Am J Clin Oncol. 2013;36:375–80. Yao K, Stewart AK, Winchester DJ, et al. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17:2554–62. Gomez SL, Lichtensztajn D, Kurian AW, et al. Increasing mastectomy rates for early-stage breast cancer? Population-based trends from California. J Clin Oncol. 2010;26:e155–57. Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 2013;20:1436–43. Canadian Institute for Health Information. Breast Cancer Surgery in Canada, 2007–2008 to 2009–2010. In: Dabbs K, Porter G, Wai E, eds. Ottawa: Canadian Institute for Health Information; 2012. https://secure.cihi.ca/free_products/BreastCancer_7-8_9-10_EN.pdf. Accessed 1 June 2014. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer risk reduction. Version 1.2014. http://www.nccn.org/professionals/physician_gls/pdf/breast_risk.pdf. Accessed 26 July 2014. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: high risk assessment: breast and ovarian. Version 1.2014. http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed 26 July 2014. King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29:2158–64. Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082–88. Brennan ME, Houssami N, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol. 2009;27:5640–9. Benedict S, Cole DJ, Baron L, et al. Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J Surg Oncol. 2001;76:6–12. Nekhlyudov L, Bower M, Herrinton LJ, et al. Women’s decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;35:55–60. Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551–6. Arrington AK, Jarosek SL, Virnig BA, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704. Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257:249–55. Hawley ST, Jagsi R, Morrow M, et al. Social and clinical determinants of contralateral prophylactic mastectomy. JAMA Surg. Epub 21 May 2014. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer. National Comprehensive Cancer Network; 2014. Coyne IT. Sampling in qualitative research. Purposeful and theoretical sampling: merging or clear boundaries? J Adv Nurs. 1997;26:623–30. Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322:1115–17. Charmaz K. Constructing grounded theory. Thousand Oaks: Sage; 2009. McCann TV, Clarke E. Grounded theory in nursing research. Part 1: methodology. Nurse Res. 2002;11:7–16. Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and action research. BMJ. 2008;337:a567. Guest G. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82. Kuzel A. Sampling in qualitative inquiry. In: Crabtree B, Miller W, eds. Doing qualitative research. Newbury Park: Sage; 1992. pp. 31–44. Charmaz K. Grounded theory in the 21st century. In: Denzin NK, Lincoln YS, eds. Handbook of qualitative research. Thousand Oaks: Sage; 2000. Rosenberg SM, Tracy MS, Meyer ME, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer. Ann Intern Med. 2013;159:373–81. Bernhardt BA, Geller G, Holtzman NA, et al. Decoding informed consent: insights from women regarding breast cancer susceptibility testing. Hastings Cent Rep. 1997;27:28–33. Kenen R, Arden-Jones A, Eeles R. We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer. Psychooncology. 2004;13:335–45. d’Agincourt-Canning L. The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns. 2005;14:55–69. Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Risky feelings: why a 6 % risk of cancer does not always feel like 6%. Patient Educ Couns. 2010;81(Suppl):S87–93. Redelmeier DA, Rozin P, Kahneman D. Understanding patients’ decisions: cognitive and emotional perspectives. JAMA. 1993;270:72–76. Borgida E, Nisbett RE. The differential impact of abstract vs. concrete information on decisions. J Appl Psychol. 1977;7:258–71. Petrie KJ, Weinman J. Patients’ perceptions of their illness. Curr Direct Psych Sci. 2012;21:60–65. Broadbent E, Petrie KJ, Main J, et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631–7. Folkman S, Lazarus RS, Gruen RJ, et al. Appraisal, coping, health status, and psychological symptoms. J Pers Soc Psychol. 1986;50:571–79. Pearlin LI, Schooler C. The structure of coping. J Health Soc Behav. 1978;19:2–21. Henselmans I, Sanderman R, Helgeson VS, et al. Personal control over the cure of breast cancer: adaptiveness, underlying beliefs and correlates. Psychooncology. 2010;19:525–34. Tomich PL, Helgeson VS. Cognitive adaptation theory and breast cancer recurrence: are there limits? J Consult Clin Psychol. 2006;74:980–7. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010:(11):CD002748. Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29:1564–9. Forbes JF, Cuzick J, Buzdar A, Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists’ Group, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008;9:45–53. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2003;56:1038–45. Rosen PP, Groshen S, Kinne DW, et al. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol. 1993;11:2090–100. Osman F, Saleh F, Jackson TD, et al. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy. Ann Surg Oncol. 2013;20:3212–7. Miller ME, Czechura T, Martz B, et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013;20:4113–20. Goldflam K, Hunt KK, Gershenwald JE, et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004;101:1977–86. Brummett CM. Chronic pain following breast surgery. Tech Reg Anesth Pain Manag. 2011;15:124–32. Gartner R, Jensen M-B, Nielsen J, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985–92. Tasmuth T, Von Smitten K, Hietanen P, et al. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol. 1995;6:453–59. Altschuler A, Nekhlyudov L, Rolnick SJ, et al. Positive, negative, and disparate: women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008;14:25–32. Frost MH, Hoskin TL, Hartmann LC, et al. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011;18:3110–6. Whelan T, Levine M, Willan A, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. 2004;292:435–41. Shaffer VA, Tomek S, Hulsey L. The effect of narrative information in a publicly available patient decision aid for early-stage breast cancer. Health Commun. 2014;29:64–73. Ubel PA, Jepson C, Baron J. The inclusion of patient testimonials in decision aids: effects on treatment choices. Med Decis Making. 2001;21:60–68. Bekker HL, Winterbottom AE, Butow P, et al. Do personal stories make patient decision aids more effective? A critical review of theory and evidence. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S9.